Ultraviolet light exerts a major part of its therapeutic efficacy against vitiligo by production of prostaglandin E2.
Namazi
M R
MR
D015415:Biomarkers / Q000032:analysis; D015232:Dinoprostone / Q000096:biosynthesis* / Q000528:radiation effects; D005260:Female; D006801:Humans; D008297:Male; D011829:Radiation Dosage; D012680:Sensitivity and Specificity; D012867:Skin / Q000378:metabolism / Q000528:radiation effects; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods*; D014820:Vitiligo / Q000175:diagnosis / Q000532:radiotherapy*
D015415:Biomarkers; D015232:Dinoprostone